Neon Laboratories Ltd.

Clindamycin

• Category :

  Intermediates/Pharmaceutical intermediates

• Synonyms :

  Methyl (7xi)-7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-D-glycero-alpha-D-galacto-octopyranoside;(2S,4R)-N-[2-chloro-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-tetrahydropyran-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide;methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-threo-alpha-D-galacto-octopyranoside;methyl 7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-beta-L-arabino-octopyranoside hydrochloride;methyl (5xi)-7-chloro-6,7,8-trideoxy-6-{[(4R)-1-methyl-4-propyl-L-prolyl]amino}-1-thio-L-glycero-alpha-D-galacto-octopyranoside hydrochloride;

• CAS NO :

  18323-44-9

• EC NO :

  242-209-1

• Molecular Formula :

  C₁₈H₃₄Cl₂N₂O₅S

• Molecular Weight :

  461.444

• Main Specifications :

• InChI :

  InChI=1/C18H33ClN2O5S.ClH/c1-5-6-10-7-11(21(3)8-10)17(25)20-12(9(2)19)16-14(23)13(22)15(24)18(26-16)27-4;/h9-16,18,22-24H,5-8H2,1-4H3,(H,20,25);1H/t9-,10+,11-,12+,13-,14+,15+,16?,18+;/m0./s1

• Molecular Structure :